{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:36:25Z","timestamp":1762497385288,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.aace.2020.11.023","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T07:38:38Z","timestamp":1610264318000},"page":"113-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal Papillary Necrosis Associated With Normocalcemic Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"7","author":[{"given":"Ismail C.","family":"Ebrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanner A.","family":"Slayden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh D.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed K.M.","family":"Shakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.aace.2020.11.023_bib1","doi-asserted-by":"crossref","first-page":"101514","DOI":"10.1016\/j.berh.2020.101514","article-title":"Primary hyperparathyroidism","volume":"34","author":"Oberger Marques","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10116","key":"10.1016\/j.aace.2020.11.023_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.aace.2020.11.023_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.aace.2020.11.023_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/2230-8210.93745","article-title":"Renal manifestations of primary hyperparathyroidism","volume":"16","author":"Lila","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.aace.2020.11.023_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.aace.2020.11.023_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mpdhp.2016.02.003","article-title":"Familial hyperparathyroidism syndromes","volume":"22","author":"Duan","year":"2016","journal-title":"Diagn Histopathol"},{"issue":"6","key":"10.1016\/j.aace.2020.11.023_bib7","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1530\/ERC-16-0059","article-title":"Endocrine neoplasms in familial syndromes of hyperparathyroidism","volume":"23","author":"Li","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.aace.2020.11.023_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9610(87)90305-9","article-title":"Carcinoids associated with multiple endocrine neoplasia syndromes","volume":"154","author":"Duh","year":"1987","journal-title":"Am J Surg"},{"issue":"8","key":"10.1016\/j.aace.2020.11.023_bib9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.aace.2020.11.023_bib10","series-title":"Advances in Treatment and Management Surgical Endocrinology","first-page":"109","article-title":"Advances in the diagnosis and management of primary hyperparathyroidism due to MEN type 1","author":"Nobecourt","year":"2020"},{"issue":"3","key":"10.1016\/j.aace.2020.11.023_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","article-title":"Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism","volume":"34","author":"Tuna","year":"2016","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"4","key":"10.1016\/j.aace.2020.11.023_bib12","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1210\/clinem\/dgaa084","article-title":"Normocalcemic hyperparathyroidism: study of its prevalence and natural history","volume":"105","author":"Schini","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.aace.2020.11.023_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.beem.2018.09.009","article-title":"Management of normocalcemic primary hyperparathyroidism","volume":"32","author":"Cusano","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.aace.2020.11.023_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9343(52)90286-6","article-title":"Renal medullary necrosis","volume":"13","author":"Mandel","year":"1952","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.aace.2020.11.023_bib15","first-page":"90","article-title":"Prostaglandin E1 for renal papillary necrosis in a patient with diabetes mellitus","volume":"27","author":"Abe","year":"1999","journal-title":"J\u00a0Int Med Res"},{"issue":"9","key":"10.1016\/j.aace.2020.11.023_bib16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.7863\/jum.2003.22.9.951","article-title":"Sonographic features of necrosed renal papillae causing hydronephrosis","volume":"22","author":"Vijayaraghavan","year":"2003","journal-title":"J\u00a0Ultrasound Med"},{"issue":"4","key":"10.1016\/j.aace.2020.11.023_bib17","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1210\/jc.2016-2481","article-title":"Thiazide treatment in primary hyperparathyroidism\u2014A new indication for an old medication?","volume":"102","author":"Tsvetov","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.aace.2020.11.023_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2265.2001.01182.x","article-title":"Relationships with serum parathyroid hormone in old institutionalized subjects","volume":"54","author":"Stein","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.aace.2020.11.023_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2796.2001.00868.x","article-title":"Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study","volume":"250","author":"Rejnmark","year":"2001","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.aace.2020.11.023_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/cen.13046","article-title":"The influence of thiazide intake on calcium and parathyroid hormone levels in patients with primary hyperparathyroidism","volume":"85","author":"Riss","year":"2016","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520310245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520310245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:31:35Z","timestamp":1762497095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060520310245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2376060520310245"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2020.11.023","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Papillary Necrosis Associated With Normocalcemic Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2020.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}